Should the Escherichia coli and Enterococcus faecalis isolated from the patient’s rectal swab be treated because the patient has a rash?

Do Not Treat E. coli and Enterococcus faecalis from Rectal Swab in a Patient with Rash

E. coli and Enterococcus faecalis isolated from a rectal swab represent normal colonizing flora of the gastrointestinal tract and should not be treated in a patient presenting with a rash, as these organisms are not causing the rash and treatment would be inappropriate.

Rationale for No Treatment

Colonization vs. Infection

The organisms isolated from your patient's rectal swab are colonizers, not pathogens in this clinical context. Both E. coli and E. faecalis are normal inhabitants of the human gastrointestinal tract 1. The presence of these bacteria in rectal swabs does not indicate infection requiring treatment.

When These Organisms Actually Require Treatment

According to established guidelines, E. coli and Enterococcus require treatment only in specific clinical scenarios:

For Enterococcus faecalis:

• Infective endocarditis - requires combination therapy with ampicillin plus gentamicin or alternative regimens 2
• Complicated intra-abdominal infections in health care-associated settings, particularly in postoperative patients, those with prior antibiotic exposure, immunocompromised patients, or those with valvular heart disease 3
• Bacteremia/sepsis with documented bloodstream infection 4

For E. coli:

• Complicated intra-abdominal infections with documented infection requiring source control 3
• Urinary tract infections with clinical symptoms 5
• Bacteremia/sepsis with positive blood cultures

The Rash Connection (or Lack Thereof)

A rash is not a manifestation of rectal colonization with E. coli or E. faecalis. These organisms do not cause dermatologic manifestations when present as normal gut flora. The rash your patient has requires evaluation for its actual cause (allergic reaction, viral exanthem, drug reaction, autoimmune condition, etc.) - not treatment of incidental rectal colonizers.

Common Clinical Pitfalls to Avoid

1. Do not treat colonization - This is a fundamental principle of antimicrobial stewardship. Treating colonizing organisms leads to:

   • Unnecessary antibiotic exposure
   • Selection for resistant organisms (including vancomycin-resistant enterococci) 1
   • Potential adverse drug effects
   • Disruption of normal protective gut flora

2. Rectal swabs detect colonization, not infection - Studies confirm that rectal swabs identify colonizing bacteria in the gastrointestinal tract 6, 7, 8, 9. The clinical utility of rectal swabs is primarily for:

   • Surveillance for multidrug-resistant organisms 1
   • Pre-procedural screening (e.g., before transrectal prostate biopsy) 6, 7
   • Infection control purposes 10

3. Correlation does not equal causation - Just because organisms are present doesn't mean they're causing the patient's symptoms.

When to Actually Culture Rectal Swabs

Rectal swabs have legitimate clinical uses, but not for diagnosing the cause of a rash:

• Surveillance for vancomycin-resistant enterococci (VRE) in high-risk patients 1
• Screening for multidrug-resistant organisms in infection control settings 1
• Pre-procedural assessment before transrectal procedures 6, 7

For infectious diarrhea evaluation, fresh stool specimens are preferred over rectal swabs, though swabs may be acceptable when timely stool cannot be obtained 11, 12.

What You Should Do Instead

Focus on the actual clinical problem:

• Evaluate the rash based on its characteristics, distribution, and associated symptoms
• Consider appropriate differential diagnoses for the rash (viral, allergic, drug-related, autoimmune, etc.)
• Order relevant diagnostic tests for the rash, not incidental findings from inappropriate screening

Do not order rectal swabs for rash evaluation - this test was either ordered inappropriately or the results are being misinterpreted in the clinical context.